Gwangju Institute of Science and Technology Researchers Discover Novel Drug Candidate to Combat Fatty Liver Disease ...Middle East

Compound 11c (GM-60106), a novel 5HT2A antagonist, paves the way for advancing metabolic liver disease treatment. GWANGJU, South Korea, April 4, 2024 /PRNewswire/ -- Metabolic dysfunction-associated steatotic liver disease (MASLD) is a burgeoning global health concern, posing a...

Hence then, the article about gwangju institute of science and technology researchers discover novel drug candidate to combat fatty liver disease was published today ( Thursday 04/04/2024 - 03:33 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Gwangju Institute of Science and Technology Researchers Discover Novel Drug Candidate to Combat Fatty Liver Disease )

Also on site :

• US trade with Southeast Asia and Taiwan surging despite Trump tariffs
• Amazon Is Selling a 'Beautiful' $19 Cherry Blossom Tree Lamp That 'Looks Lovely at Night'
• NYT Connections Sports Edition Today: Hints and Answers for Wednesday, January 21, 2026